NASDAQ:APDN Applied DNA Sciences - APDN Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Applied DNA Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.47 0.00 (0.00%) (As of 01/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.41▼$1.5050-Day Range$1.22▼$1.6952-Week Range$0.62▼$7.35Volume85,729 shsAverage Volume164,629 shsMarket Capitalization$18.98 millionP/E RatioN/ADividend YieldN/APrice Target$4.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Applied DNA Sciences MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside172.1% Upside$4.00 Price TargetShort InterestHealthy5.48% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.79Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.91 out of 5 starsIndustrial Products Sector127th out of 183 stocksMiscellaneous Business Services Industry5th out of 6 stocks 3.5 Analyst's Opinion Consensus RatingApplied DNA Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.00, Applied DNA Sciences has a forecasted upside of 172.1% from its current price of $1.47.Amount of Analyst CoverageApplied DNA Sciences has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted5.48% of the outstanding shares of Applied DNA Sciences have been sold short.Short Interest Ratio / Days to CoverApplied DNA Sciences has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Applied DNA Sciences has recently decreased by 20.67%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldApplied DNA Sciences does not currently pay a dividend.Dividend GrowthApplied DNA Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for APDN. Previous Next 2.7 News and Social Media Coverage News SentimentApplied DNA Sciences has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.60 average news sentiment score of Industrial Products companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Applied DNA Sciences this week, compared to 2 articles on an average week.Search InterestOnly 6 people have searched for APDN on MarketBeat in the last 30 days. This is a decrease of -54% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Applied DNA Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Applied DNA Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.37% of the stock of Applied DNA Sciences is held by insiders.Percentage Held by InstitutionsOnly 15.27% of the stock of Applied DNA Sciences is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Applied DNA Sciences is -0.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Applied DNA Sciences is -0.92, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApplied DNA Sciences has a P/B Ratio of 1.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Applied DNA Sciences (NASDAQ:APDN) StockApplied DNA Sciences, Inc. engages in developing and marketing technologies to produce and detect deoxyribonucleic acid. It operates through the following segments: Therapeutic DNA Production, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production segment consists of the manufacture of DNA for use in nucleic acid-based therapeutics. The MDx Testing Services segment is involved in performing and developing clinical molecular diagnostic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment includes manufacture and detection of DNA for industrial supply chain security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.Read More Receive APDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address APDN Stock News HeadlinesJanuary 29, 2023 | americanbankingnews.comApplied DNA Sciences (NASDAQ:APDN) Lifted to Hold at StockNews.comJanuary 23, 2023 | americanbankingnews.comApplied DNA Sciences, Inc. (NASDAQ:APDN) Sees Significant Decrease in Short InterestJanuary 29, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.January 5, 2023 | finance.yahoo.comApplied DNA Announces Publication of Peer-Reviewed Journal Article Validating Potential Use of linearDNA™ as a New Class of DNA-Based VaccinesDecember 22, 2022 | finance.yahoo.comApplied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2022 Earnings Call TranscriptDecember 17, 2022 | seekingalpha.comApplied DNA Sciences, Inc. (APDN) Q4 2022 Earnings Call TranscriptDecember 16, 2022 | finance.yahoo.comApplied DNA Sciences Full Year 2022 Earnings: EPS Beats Expectations, Revenues LagDecember 14, 2022 | finance.yahoo.comApplied DNA Announces Fourth Quarter and Fiscal Year 2022 Financial ResultsJanuary 29, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.December 13, 2022 | msn.comEarnings Outlook For Applied DNA SciencesDecember 12, 2022 | finance.yahoo.comApplied DNA to Report Fiscal 2022 Fourth Quarter and Year End Financial Results on December 14, 2022October 24, 2022 | benzinga.comApplied DNA to Establish North America's First Enzymatic (Cell Free) Large-Scale cGMP DNA Manufacturing Capacity in Suffolk County, New YorkOctober 24, 2022 | finance.yahoo.comApplied DNA to Establish North America’s First Enzymatic (Cell Free) Large-Scale cGMP DNA Manufacturing Capacity in Suffolk County, New YorkOctober 18, 2022 | finance.yahoo.comApplied DNA Sciences Stock Surges On largest LinearDNA ContractOctober 10, 2022 | nasdaq.comApplied DNA Sciences Surges On Receipt Of Largest Single Purchase Order For LinearDNAOctober 10, 2022 | benzinga.comThinking about buying stock in Ford, Applied DNA Sciences, Nio, Credit Suisse, or Rivian Automotive?October 10, 2022 | seekingalpha.comApplied DNA climbs 51% after winning large purchase orderOctober 10, 2022 | finance.yahoo.comApplied DNA Announces Receipt of Largest Single Purchase Order for LinearDNA™ To-DateSeptember 30, 2022 | finance.yahoo.comApplied DNA’s Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in FerretsSeptember 28, 2022 | seekingalpha.comAPDN Applied DNA Sciences, Inc.September 24, 2022 | finance.yahoo.comApplied DNA Sciences, Inc. (APDN)September 8, 2022 | finance.yahoo.comApplied DNA and the Cornell University College of Veterinary Medicine Announce Research Collaboration to Accelerate Application of LinearDNA™ Platform for Veterinary Health ApplicationsSeptember 7, 2022 | finance.yahoo.comApplied DNA to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022September 6, 2022 | finance.yahoo.comApplied DNA Launches Monkeypox Testing ServiceAugust 19, 2022 | finance.yahoo.comApplied DNA Submits PCR-based Monkeypox Virus Diagnostic Test for Approval to New York State Department of HealthAugust 17, 2022 | finance.yahoo.comAnalyst Forecasts For Applied DNA Sciences, Inc. (NASDAQ:APDN) Are Surging HigherAugust 12, 2022 | seekingalpha.comApplied DNA Sciences stock falls ~14% after massive runup last week, Q3 resultsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive APDN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied DNA Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address APDN Company Calendar Last Earnings8/11/2021Today1/29/2023Next Earnings (Estimated)2/09/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Miscellaneous business services Sub-IndustryN/A SectorIndustrial Products Current SymbolNASDAQ:APDN CUSIPN/A CIK744452 Webwww.adnas.com Phone(631) 240-8800Fax631-240-8900Employees78Year FoundedN/APrice Target and Rating Average Stock Price Forecast$4.00 High Stock Price Forecast$5.00 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+172.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.59) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,270,000.00 Net Margins-45.51% Pretax Margin-45.52% Return on Equity-116.59% Return on Assets-70.08% Debt Debt-to-Equity RatioN/A Current Ratio4.77 Quick Ratio4.62 Sales & Book Value Annual Sales$18.17 million Price / Sales1.04 Cash FlowN/A Price / Cash FlowN/A Book Value$1.08 per share Price / Book1.36Miscellaneous Outstanding Shares12,910,000Free Float12,087,000Market Cap$18.98 million OptionableOptionable Beta0.53 Key ExecutivesJames A. HaywardChairman, President & Chief Executive OfficerJudy MurrahChief Operating OfficerBeth M. JantzenChief Financial Officer & ControllerLawrence JungAssociate Director-Research & DevelopmentFrank CiprianiAssociate Director-ProductionKey CompetitorsDigital AllyNASDAQ:DGLYLiqTech InternationalNASDAQ:LIQTAsia Pacific Wire & CableNASDAQ:APWCPresidio Property TrustNASDAQ:SQFTArt's-Way ManufacturingNASDAQ:ARTWView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 142,000 shares on 11/15/2022Ownership: 2.946%Citadel Advisors LLCBought 333,700 shares on 11/15/2022Ownership: 0.000%Two Sigma Investments LPBought 128,825 shares on 11/15/2022Ownership: 1.075%BlackRock Inc.Bought 39,541 shares on 11/15/2022Ownership: 0.849%State Street CorpBought 48,700 shares on 11/15/2022Ownership: 0.632%View All Institutional Transactions APDN Stock - Frequently Asked Questions Should I buy or sell Applied DNA Sciences stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Applied DNA Sciences in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" APDN shares. View APDN analyst ratings or view top-rated stocks. What is Applied DNA Sciences' stock price forecast for 2023? 1 brokerages have issued 1-year target prices for Applied DNA Sciences' shares. Their APDN share price forecasts range from $3.00 to $5.00. On average, they expect the company's share price to reach $4.00 in the next year. This suggests a possible upside of 172.1% from the stock's current price. View analysts price targets for APDN or view top-rated stocks among Wall Street analysts. How have APDN shares performed in 2023? Applied DNA Sciences' stock was trading at $1.66 at the start of the year. Since then, APDN stock has decreased by 11.4% and is now trading at $1.47. View the best growth stocks for 2023 here. When is Applied DNA Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 9th 2023. View our APDN earnings forecast. How were Applied DNA Sciences' earnings last quarter? Applied DNA Sciences, Inc. (NASDAQ:APDN) posted its earnings results on Wednesday, August, 11th. The technology company reported ($0.46) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by $0.20. The technology company earned $1.70 million during the quarter, compared to analyst estimates of $3.44 million. Applied DNA Sciences had a negative net margin of 45.51% and a negative trailing twelve-month return on equity of 116.59%. What is James A. Hayward's approval rating as Applied DNA Sciences' CEO? 2 employees have rated Applied DNA Sciences Chief Executive Officer James A. Hayward on Glassdoor.com. James A. Hayward has an approval rating of 100% among the company's employees. This puts James A. Hayward in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Applied DNA Sciences to a friend. What other stocks do shareholders of Applied DNA Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Applied DNA Sciences investors own include Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Ekso Bionics (EKSO), Micron Technology (MU), Arbutus Biopharma (ABUS), VBI Vaccines (VBIV), Gilead Sciences (GILD), Vaxart (VXRT), Sorrento Therapeutics (SRNE) and Intel (INTC). What is Applied DNA Sciences' stock symbol? Applied DNA Sciences trades on the NASDAQ under the ticker symbol "APDN." Who are Applied DNA Sciences' major shareholders? Applied DNA Sciences' stock is owned by a number of institutional and retail investors. Top institutional investors include FNY Investment Advisers LLC (0.00%). View institutional ownership trends. How do I buy shares of Applied DNA Sciences? Shares of APDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Applied DNA Sciences' stock price today? One share of APDN stock can currently be purchased for approximately $1.47. How much money does Applied DNA Sciences make? Applied DNA Sciences (NASDAQ:APDN) has a market capitalization of $18.98 million and generates $18.17 million in revenue each year. The technology company earns $-8,270,000.00 in net income (profit) each year or ($1.59) on an earnings per share basis. How can I contact Applied DNA Sciences? Applied DNA Sciences' mailing address is 50 HEALTH SCIENCES DRIVE, STONY BROOK NY, 11790. The official website for the company is www.adnas.com. The technology company can be reached via phone at (631) 240-8800, via email at investor@adnas.com, or via fax at 631-240-8900. This page (NASDAQ:APDN) was last updated on 1/29/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.